417 related articles for article (PubMed ID: 34012113)
1. MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration.
Simone R; Javad F; Emmett W; Wilkins OG; Almeida FL; Barahona-Torres N; Zareba-Paslawska J; Ehteramyan M; Zuccotti P; Modelska A; Siva K; Virdi GS; Mitchell JS; Harley J; Kay VA; Hondhamuni G; Trabzuni D; Ryten M; Wray S; Preza E; Kia DA; Pittman A; Ferrari R; Manzoni C; Lees A; Hardy JA; Denti MA; Quattrone A; Patani R; Svenningsson P; Warner TT; Plagnol V; Ule J; de Silva R
Nature; 2021 Jun; 594(7861):117-123. PubMed ID: 34012113
[TBL] [Abstract][Full Text] [Related]
2. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy.
Ferrer I; Andrés-Benito P; Zelaya MV; Aguirre MEE; Carmona M; Ausín K; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E; Del Rio JA
Acta Neuropathol; 2020 Apr; 139(4):735-771. PubMed ID: 31907603
[TBL] [Abstract][Full Text] [Related]
3. Tau alternative splicing in familial and sporadic tauopathies.
Niblock M; Gallo JM
Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
5. A novel tau mutation, p.K317N, causes globular glial tauopathy.
Tacik P; DeTure M; Lin WL; Sanchez Contreras M; Wojtas A; Hinkle KM; Fujioka S; Baker MC; Walton RL; Carlomagno Y; Brown PH; Strongosky AJ; Kouri N; Murray ME; Petrucelli L; Josephs KA; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
Acta Neuropathol; 2015 Aug; 130(2):199-214. PubMed ID: 25900293
[TBL] [Abstract][Full Text] [Related]
6. Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.
Iovino M; Agathou S; González-Rueda A; Del Castillo Velasco-Herrera M; Borroni B; Alberici A; Lynch T; O'Dowd S; Geti I; Gaffney D; Vallier L; Paulsen O; Káradóttir RT; Spillantini MG
Brain; 2015 Nov; 138(Pt 11):3345-59. PubMed ID: 26220942
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA SNHG8 drives stress granule formation in tauopathies.
Bhagat R; Minaya MA; Renganathan A; Mehra M; Marsh J; Martinez R; Eteleeb AM; Nana AL; Spina S; Seeley WW; Grinberg LT; Karch CM
Mol Psychiatry; 2023 Nov; 28(11):4889-4901. PubMed ID: 37730840
[TBL] [Abstract][Full Text] [Related]
8. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies.
Karch CM; Jeng AT; Goate AM
J Biol Chem; 2012 Dec; 287(51):42751-62. PubMed ID: 23105105
[TBL] [Abstract][Full Text] [Related]
10. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Strang KH; Golde TE; Giasson BI
Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
[TBL] [Abstract][Full Text] [Related]
11. Brief update on different roles of tau in neurodegeneration.
Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
[TBL] [Abstract][Full Text] [Related]
12. Familial tauopathy with P364S MAPT mutation: clinical course, neuropathology and ultrastructure of neuronal tau inclusions.
Štrafela P; Pleško J; Magdič J; Koritnik B; Zupan A; Glavač D; Bresjanac M; Popović M
Neuropathol Appl Neurobiol; 2018 Oct; 44(6):550-562. PubMed ID: 29215752
[TBL] [Abstract][Full Text] [Related]
13. Tauopathies as clinicopathological entities.
Irwin DJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
[TBL] [Abstract][Full Text] [Related]
14. Disentangling the role of the tau gene locus in sporadic tauopathies.
Vandrovcova J; Anaya F; Kay V; Lees A; Hardy J; de Silva R
Curr Alzheimer Res; 2010 Dec; 7(8):726-34. PubMed ID: 20704554
[TBL] [Abstract][Full Text] [Related]
15. Tau silencing by siRNA in the P301S mouse model of tauopathy.
Xu H; Rösler TW; Carlsson T; de Andrade A; Fiala O; Hollerhage M; Oertel WH; Goedert M; Aigner A; Höglinger GU
Curr Gene Ther; 2014; 14(5):343-51. PubMed ID: 25687501
[TBL] [Abstract][Full Text] [Related]
16. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
Rademakers R; Cruts M; van Broeckhoven C
Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
[TBL] [Abstract][Full Text] [Related]
17. Tau and MAPT genetics in tauopathies and synucleinopathies.
Leveille E; Ross OA; Gan-Or Z
Parkinsonism Relat Disord; 2021 Sep; 90():142-154. PubMed ID: 34593302
[TBL] [Abstract][Full Text] [Related]
18. Cellular and pathological heterogeneity of primary tauopathies.
Chung DC; Roemer S; Petrucelli L; Dickson DW
Mol Neurodegener; 2021 Aug; 16(1):57. PubMed ID: 34425874
[TBL] [Abstract][Full Text] [Related]
19. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
[TBL] [Abstract][Full Text] [Related]
20. The seeds of its regulation: natural antisense transcripts as single-gene control switches in neurodegenerative disorders.
Lahiri DK; Maloney B; Wang R; White FA; Sambamurti K; Greig NH; Counts SE
Ageing Res Rev; 2024 May; ():102336. PubMed ID: 38740308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
